Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00966953 · ClinicalTrials.gov registry record · Phase 3
Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 25
- Enrollment target
NCT00966953: Completed Phase 3 study, sponsored by Colgate Palmolive.
NCT00966953 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 25 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00966953, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 25 participants
- Enrollment target
Study Summary
Clinical research study to determine the anti-plaque efficacy of prototype dentifrices via a 4-day brushing regiment
Primary Outcome
Plaque score scale: Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)
Interventions
- DRUG Fluoride
- DRUG Triclosan/Fluoride toothpaste
- OTHER antibacterial plant extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-01 |
| Phase | Phase 3 |
What the finished NCT00966953 record still lists
NCT00966953 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Fluoride is the first listed.
NCT00966953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00966953 about?
NCT00966953 is a clinical study titled "Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.". Clinical research study to determine the anti-plaque efficacy of prototype dentifrices via a 4-day brushing regiment
What is the current status of trial NCT00966953?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 25 participants. The study started on 2007-10. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00966953?
The interventions under investigation include: Fluoride (DRUG), Triclosan/Fluoride toothpaste (DRUG), antibacterial plant extract (OTHER).
Who is sponsoring clinical trial NCT00966953?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00966953's enrollment target sits among peer trials
25 1941st of 2000 higher than 58 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia